USPTO 2015–2025 USPTO PatentsView US Corporation

Poly-med, Inc.

USPTO PatentsView assignee record - 57 granted patents across 30 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.1

Avg claims per patent

-3%

5-year filing velocity

The verdict

Poly-med holds 57 US patents across 30 technology areas, rank #5,970 of 50,000 tracked assignees.

#5,970
of 50,000 US assignees by volume: Top 5%
by Innovation Score (58.3/100): 16.1
avg claims per patent: -3%
filing velocity, last 5 yrs

Portfolio overview

Poly-med, Inc. has been granted 57 US utility patents between 2015 and 2025, placing Poly-med, Inc. at rank #5,970 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Poly-med, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Poly-med sits between Ovonyx Memory Technology, Llc (57 patents, rank #5,966) and Rhode Island Hospital (57 patents, rank #5,974) - the closest US assignees by grant volume. The composite Innovation Score of 58.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 28 grants, compared with 29 in the 2015–2019 window, a -3% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Poly-med, Inc.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Poly-med, Inc. against peers pursuing similar technology classes.

Ovonyx Memory Tec…

57
Phytogen SEED

57
Preformed LINE Pr…

57
Pangu Biopharma

57
Production Resour…

57
Quantenna Communi…

57
Raysearch Laborat…

57
Rhode Island Hosp…

57
Poly-med ◀

57

What this shows Poly-med holds 57 patents at rank #5,970, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Poly-med

By rank, the assignees closest to #5,970 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Poly-med's primary technology class.

Poly-med's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Poly-med, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	13	22.8%
2016	9	15.8%
2017	2	3.5%
2018	4	7.0%
2019	1	1.8%
2020	2	3.5%
2021	4	7.0%
2022	2	3.5%
2023	5	8.8%
2024	9	15.8%
2025	6	10.5%

Which technologies does Poly-med, Inc. patent most?

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 37

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 25

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 18

D10B - INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES 16

D01D - MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS 14

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 13

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 9

D04B - KNITTING 9

D01F - CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS 8

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 8

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 7

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 7

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 6

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 6

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 6

Top 15 of 30 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#5,970

Across all tracked assignees

Innovation Score

58.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Poly-med, Inc. hold?

Poly-med, Inc. holds 57 US granted patents filed between 2015 and 2025, spanning 30 technology areas.

What is Poly-med, Inc.'s Innovation Score?

Poly-med, Inc. has an Innovation Score of 58.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Poly-med, Inc. focus on?

Poly-med, Inc.'s top technology area is A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES) with 37 patents. The company has filed patents in 30 CPC subclasses total.

Is Poly-med, Inc.'s patent filing rate increasing or decreasing?

Poly-med, Inc.'s recent filing velocity is -3% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Poly-med, Inc.'s patents?

Poly-med, Inc.'s patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the Poly-med, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Poly-med's 57 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Poly-med ranks #5,970 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61L - see who else leads that technology area. A61L leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.